Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

Researchers in Shanghai have made a major clinical-stage breakthrough in brain-computer interfaces (BCI) researches by ...

Every year, roughly 5,000 people are diagnosed with Amyotrophic Lateral Sclerosis, which is why ALS in the Heartland chooses ...

The motor neuron disease treatment market is witnessing substantial growth, primarily fueled by the rising incidence of conditions like Amyotrophic L ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...

BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...

Motor neurone disease (MND) is a rare but progressive neurological disorder characterised by the degeneration of motor ...

US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...